$ADIL ADIAL PHARMACEUTICALS, INC. Insider Trading
Get free email notifications about insider trading in ADIAL PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ADIAL PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in ADIAL PHARMACEUTICALS, INC. for free.
CIK Number: 0001513525
IRS Number: 800667150
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ADIL
Company Address: 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE 22901
Phone number: (434) 422-9800
Former name: Adial Pharmaceuticals, L.L.C., date of change: 2011-02-18
ADIAL PHARMACEUTICALS, INC. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 08 2021 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Sell | S | 2.50 | 150,000 | 375,000 | 548,336 | 698.3 K to 548.3 K (-21.48 %) |
Apr 08 2021 | ADIL | ADIAL PHARMACEUTIC ... | Johnson Bankole A. | Chief Medical Offic ... | Sell | S | 2.50 | 150,000 | 375,000 | 548,336 | 698.3 K to 548.3 K (-21.48 %) |
Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Truluck Joseph | Chief Financial Off ... | Option Exercise | A | 3.11 | 125,000 | 388,750 | 125,000 | |
Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | A | 3.11 | 250,000 | 777,500 | 250,000 | |
Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | A | 3.11 | 40,000 | 124,400 | 40,000 | |
Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | A | 3.11 | 40,000 | 124,400 | 40,000 | |
Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Goodman Tony | Director | Option Exercise | A | 3.11 | 40,000 | 124,400 | 40,000 | |
Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Option Exercise | A | 3.11 | 40,000 | 124,400 | 40,000 | |
Feb 10 2021 | ADIL | ADIAL PHARMACEUTIC ... | Anderson J. Kermit | Director | Option Exercise | A | 3.11 | 40,000 | 124,400 | 40,000 | |
Jan 28 2021 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Grant | A | 0.00 | 201,109 | 0 | 917,046 | 715.9 K to 917 K (+28.09 %) |
Jan 28 2021 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Grant | A | 0.00 | 2,544 | 0 | 152,963 | 150.4 K to 153 K (+1.69 %) |
Jan 28 2021 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Grant | A | 0.00 | 1,187 | 0 | 14,475 | 13.3 K to 14.5 K (+8.93 %) |
Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 5.00 | 89,600 | 448,000 | 0 | |
Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 5.00 | 89,600 | 448,000 | 0 | |
Nov 25 2020 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | G | 6.25 | 82,461 | 515,381 | 0 |